News & Updates

Baseline IOP predicts treatment response for SLT, PGA drops

11 Dec 2024 by

Primary treatment with either selective laser trabeculoplasty (SLT) or prostaglandin analog (PGA) drops for ocular hypertension and open-angle glaucoma results in a decrease in intraocular pressure (IOP), and this benefit is greater with higher baseline IOP, a study has shown.

Baseline IOP predicts treatment response for SLT, PGA drops

11 Dec 2024

Risk of depression high in retinitis pigmentosa

24 Nov 2024

Retinitis pigmentosa may predispose patients to depression, as reported in a retrospective study.

Risk of depression high in retinitis pigmentosa

24 Nov 2024

RLRL therapy beneficial in children with high myopia

23 Nov 2024

Treatment with repeated low-level red light (RLRL) shows greater efficacy among children and adolescents with high myopia, resulting in substantial axial shortening, reports a study.

RLRL therapy beneficial in children with high myopia

23 Nov 2024

$Visual impairment is mainly caused by cataract, glaucoma and diabetic retinopathy in older persons and untreated refractive e$

Visual impairment is mainly caused by cataract, glaucoma and diabetic retinopathy in older persons and untreated refractive error in children.

18 Nov 2024 by

A study in University of Malaya Medical Centre (UMMC) underscored the need for early detection of visual impairment in preventing blindness in every age group.

Visual impairment is mainly caused by cataract, glaucoma and diabetic retinopathy in older persons and untreated refractive error in children.

18 Nov 2024

Patients with acute anterior uveitis prone to ipsilateral recurrence

12 Nov 2024

Recurrence in the ipsilateral eye is not uncommon in nearly half of patients with acute anterior uveitis (AAU), while one in four may experience recurrence in the contralateral eye, suggests a study.

Patients with acute anterior uveitis prone to ipsilateral recurrence

12 Nov 2024

Faricimab trumps aflibercept in diabetic macular edema

12 Nov 2024

Treatment with faricimab demonstrates similar visual acuity and greater retinal thickness reduction, with fewer injections, when compared with aflibercept therapy in patients with diabetic macular edema (DME), reports a recent study.

Faricimab trumps aflibercept in diabetic macular edema

12 Nov 2024

Faricimab vs aflibercept for DME in BCVA 20/50 or worse: Reduced retinal thickness, fewer jabs

05 Nov 2024

In the treatment of diabetic macular edema (DME) in the subgroup of patients with baseline best-corrected visual acuity (BCVA) of 20/50 or worse, the bispecific antibody faricimab has been shown to improve visual acuity as much as the anti-VEGF aflibercept, with the added advantage of a greater decrease in retinal thickness and reduced injection frequency.

Faricimab vs aflibercept for DME in BCVA 20/50 or worse: Reduced retinal thickness, fewer jabs

05 Nov 2024

3 cycles of chemo enough for high-risk retinoblastoma in children

04 Nov 2024 by

Shortening the postenucleation chemotherapy regimen containing carboplatin, etoposide, and vincristine (CEV) from six to three cycles results in comparable survival outcomes in paediatric patients with unilateral pathologic high-risk retinoblastoma, according to new research.

3 cycles of chemo enough for high-risk retinoblastoma in children

04 Nov 2024

$Maternal FPG levels predict refractive errors, astigmatism in kids$

Maternal FPG levels predict refractive errors, astigmatism in kids

03 Nov 2024

During pregnancy, high levels of maternal fasting plasma glucose (FPG) trajectories appear to contribute to refractive error, hypermetropia, and astigmatism in children at 6 years of age, reveals a recent study.

Maternal FPG levels predict refractive errors, astigmatism in kids

03 Nov 2024

Curcuma-based supplements show promise for age-related macular degeneration

02 Nov 2024

Curcuma-based nutritional supplements have the potential to reduce the risk of incident age-related macular degeneration (AMD) or progression to later stages of AMD, according to a retrospective study.

Curcuma-based supplements show promise for age-related macular degeneration

02 Nov 2024

News & Updates

Filter by Specialty:

Specialty:

Baseline IOP predicts treatment response for SLT, PGA drops

Baseline IOP predicts treatment response for SLT, PGA drops

Risk of depression high in retinitis pigmentosa

Risk of depression high in retinitis pigmentosa

RLRL therapy beneficial in children with high myopia

RLRL therapy beneficial in children with high myopia

Visual impairment is mainly caused by cataract, glaucoma and diabetic retinopathy in older persons and untreated refractive error in children.

Visual impairment is mainly caused by cataract, glaucoma and diabetic retinopathy in older persons and untreated refractive error in children.

Patients with acute anterior uveitis prone to ipsilateral recurrence

Patients with acute anterior uveitis prone to ipsilateral recurrence

Faricimab trumps aflibercept in diabetic macular edema

Faricimab trumps aflibercept in diabetic macular edema

Faricimab vs aflibercept for DME in BCVA 20/50 or worse: Reduced retinal thickness, fewer jabs

Faricimab vs aflibercept for DME in BCVA 20/50 or worse: Reduced retinal thickness, fewer jabs

3 cycles of chemo enough for high-risk retinoblastoma in children

3 cycles of chemo enough for high-risk retinoblastoma in children

Maternal FPG levels predict refractive errors, astigmatism in kids

Maternal FPG levels predict refractive errors, astigmatism in kids

Curcuma-based supplements show promise for age-related macular degeneration

Curcuma-based supplements show promise for age-related macular degeneration